【摘要】 目的探讨在中国较大样本的胃肠道间质瘤(GIST)中c-kit基因和PDGFRA基因的突变状况,为进一步的生物靶向治疗提供依据。方法用免疫组织化学EnVision法、聚合酶链反应(PCR)扩增和直接测序的方法,检测165例GISTc-kit基因9、11、13和17号外显子突变以及PDGFRA基因12和18号外显子突变。结果病理组织学诊断的165例GIST病例中有155例(94%)免疫组织化学显示CD117阳性。在CD117阳性的GIST中,c-kit基因总突变率为76·1%(118/155):分别为11号外显子67·1%(104/155)、9号外显子7·1%(11/155)、13号外显子1·3%(2/155)和17号外显子0·6%(1/155)。绝大多数为杂合性突变,少数为纯合性突变。11号外显子的突变位点多集中在5′端的经典热点,其次为3′端的框内串联重复。后者主要以核分裂象少的老年女性胃部病例多见。9号外显子突变代表一类发生在年轻男性体积较大的小肠病变。13号外显子发现一处新的突变点L641P。PDGFRA基因突变见于50%(5/10)CD117阴性病例,均为18号外显子突变,包括常见的D842V点突变和一个框内843~846处IMHD缺失伴有S847T的新突变。PDGFRA基因突变多见于发生在后腹膜/网膜的具有高度侵袭危险性的病例。结论中国GIST病例大多数存在c-kit基因和PDGFRA基因的突变,且在基因突变类型和肿瘤原发部位间有非随机的联系。除了发现几个新的突变形式外,国人的GIST似乎和西方国家有些不同的突变特点。靶向治疗需要基因突变分型的启示和指导。更多还原

【Abstract】 Objective To investigate the status of c-kit and PDGFRA mutations of GIST in a the large sample of Chinese patients. Method One hundred and sixty-five cases were evaluated for the presence of c-kit and PDGFRA mutations. Exon 9,11,13,17 of c-kit and exon 12, 18 of PDGFRA were analyzed by PCR amplification and direct sequencing. Results Immunohistochemical demonstrations of KIT (CD117) were seen in 94% of the cases (155/165). Overall, c-kit mutations were identified in 76.1% (118/155) of CD117 positive cases: 67.1% (104/155) involving exon 11, 7.1%(11/155) involving exon 9, 1.3% (2/155) involving exon 13 and 0.6% (1/155) involving exon 17. The c-kit exon 11 mutations were mostly heterogeneous and clustered in the classic “hot spot” at the 5′ end of the exon, including in-frame deletion and point mutation. The second “hot spots” were internal tandem duplications (ITD) at the 3’ end of the exon, which were associated with female patient, older age, stomach location and low mitotic counts. The exon 9 mutations correlated with a distinct subset of GISTs involving the small bowel of young male patients. A new point mutation of L641P was identified in exon 13. PDGFRA mutations were present in 50% (5/10) of CD117-negative GISTs, all involving exon 18 with the majority of mutations being D842V. One novel in-frame deletion of IMHD mutation at codon 843-846 with S847T was identified. GISTs with PDGFRA mutations were often larger tumors arising from the omentum/mesentery of young male patients with high risk of aggressive behavior. Conclusions The vast majority of GISTs in this study harbored c-kit and PDGFRA mutations, there were non-random relations between the gene mutation patterns and the locations of GISTs. It appears that Chinese GIST patients have some unique mutation patterns. It is necessary to evaluate the gene mutations status of GISTs to guide target therapy.更多还原